Dupilumab in adolescents with moderate to severe atopic dermatitis: a 32-week real-world experience during the COVID-19 pandemic

Autor:	M C Fargnoli, Teresa Grieco, Katharina Hansel, Giovanni Pellacani, Gabriella Fabbrocini, Cataldo Patruno, Viviana Piras, Elisabetta Antonelli, Myriam Zucca, Giampiero Girolomoni, Luca Stingeni, G Dal Bello, Maddalena Napolitano, Maria Esposito
Přispěvatelé:	Hansel, K., Patruno, C., Antonelli, E., Dal Bello, G., Napolitano, M., Fabbrocini, G., Grieco, T., Pellacani, G., Fargnoli, M. C., Esposito, M., Piras, V., Zucca, M., Girolomoni, G., Stingeni, L.
Jazyk:	angličtina
Rok vydání:	2022
Předmět:	Moderate to severe Male medicine.medical_specialty 2019-20 coronavirus outbreak Coronavirus disease 2019 (COVID-19) Adolescent Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Dermatitis Dermatology Antibodies Monoclonal Humanized Antibodies Atopic Dermatitis Atopic Pandemic Correspondence Monoclonal medicine COVID-19 Female Humans Italy Prospective Studies Treatment Outcome Letter to the Editor Humanized business.industry Atopic dermatitis medicine.disease Dupilumab Prospective Studie business Human
Zdroj:	Clinical and Experimental Dermatology
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::475a081732b617d2e9bffdeeab7f713a http://hdl.handle.net/11562/1056895 Zobrazit plný text záznamu